OpenLB
Open Library of Bioscience
Advanced Search
The New England journal of medicine
02 10, 2022;386 (6): 599-601.

Plasma Neutralization of the SARS-CoV-2 Omicron Variant.

Fabian Schmidt, Frauke Muecksch, Yiska Weisblum, Justin Da Silva, Eva Bednarski, Alice Cho, Zijun Wang, Christian Gaebler, Marina Caskey, Michel C Nussenzweig, Theodora Hatziioannou, Paul D Bieniasz
Author Information
  1. Fabian Schmidt: Rockefeller University, New York, NY pbieniasz@rockefeller.edu.
  2. Frauke Muecksch: Rockefeller University, New York, NY pbieniasz@rockefeller.edu.
  3. Yiska Weisblum: Rockefeller University, New York, NY pbieniasz@rockefeller.edu.
  4. Justin Da Silva: Rockefeller University, New York, NY pbieniasz@rockefeller.edu.
  5. Eva Bednarski: Rockefeller University, New York, NY pbieniasz@rockefeller.edu.
  6. Alice Cho: Rockefeller University, New York, NY pbieniasz@rockefeller.edu.
  7. Zijun Wang: Rockefeller University, New York, NY pbieniasz@rockefeller.edu.
  8. Christian Gaebler: Rockefeller University, New York, NY pbieniasz@rockefeller.edu.
  9. Marina Caskey: Rockefeller University, New York, NY pbieniasz@rockefeller.edu.
  10. Michel C Nussenzweig: Rockefeller University, New York, NY pbieniasz@rockefeller.edu.
  11. Theodora Hatziioannou: Rockefeller University, New York, NY pbieniasz@rockefeller.edu.
  12. Paul D Bieniasz: Rockefeller University, New York, NY pbieniasz@rockefeller.edu. ORCID
PMID: 35030645 DOI: 10.1056/NEJMc2119641

Abstract

No abstract text available.

Grants

  1. R01 AI078788/NIAID NIH HHS
  2. UL1 TR001866/NCATS NIH HHS
  3. P01-AI138398-S1/National Institute of Allergy and Infectious Diseases
  4. R37AI64003/National Institute of Allergy and Infectious Diseases
  5. 2U19AI111825/National Institute of Allergy and Infectious Diseases
  6. R37 AI064003/NIAID NIH HHS
  7. R01AI501111/National Institute of Allergy and Infectious Diseases
  8. U19 AI111825/NIAID NIH HHS
  9. R01AI78788/National Institute of Allergy and Infectious Diseases
  10. UL1 TR001866/NCATS NIH HHS
  11. /Howard Hughes Medical Institute

MeSH Term

Antibodies, Neutralizing
Antibodies, Viral
COVID-19
COVID-19 Vaccines
Humans
Immunogenicity, Vaccine
SARS-CoV-2

Chemicals

Antibodies, Neutralizing
Antibodies, Viral
COVID-19 Vaccines
Letter Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't
Article has an altmetric score of 435

Word Cloud

Created with Highcharts 10.0.0PlasmaNeutralizationSARS-CoV-2OmicronVariant

Similar Articles

Cited By (292)